Endocrine Journal · 2012 · 25 citations · 23 references
MedicineEndocrinologyPharmacologyClinical PharmacologyDiabetologyGeneral PharmacologyBlood Glucose MonitoringContinuous Glucose MonitoringDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlGlycemic MonitoringAntidiabetic Drug TherapyBlood Glucose RegulationCombination Antidiabetic TherapyCombination TherapyDiabetes Medication UseGlucose MonitoringGlucose-stimulated Insulin SecretionGlycemic Excursions
Acarbose was administered at 300 mg/day to patients with type 2 diabetes mellitus (T2DM) who had been taking 25 mg/day of alogliptin, and levels of blood glucose were analyzed by continuous glucose monitoring (CGM) for 3 days. The mean blood glucose level with acarbose (136.4 ± 30.7 mg/dL) did not differ significantly from that without acarbose (141.7 ± 28.3 mg/dL). However, in the condition of the combination therapy, there were significant decreases in the standard deviation of the mean blood glucose levels for the 24-hour period (27.6 ± 9.1 vs. 16.2 ± 6.9 mg/dL, p<0.001) and mean amplitude of glycemic excursions (MAGE) (65.8 ± 26.1 vs. 38.8 ± 19.2 mg/dL, p=0.010). In addition, a meal tolerance test was conducted to monitor changes in insulin secretion and active GLP-1 and total GIP values. Ten subjects (5 males, 5 females) of 54.9 ± 6.9 years with BMI 25.9 ± 5.2 kg/m² and HbAlc 9.2 ± 1.2% were enrolled. In the meal tolerance test, active GLP-1 values before and after acarbose administration were 17.0 ± 5.8 and 24.1 ± 9.3 pmol·hr/mL (p=0.054), respectively, showing an increasing tendency, and total GIP(AUC0-180) values were 685.9 ± 209.7 and 404.4 ± 173.7 pmol·hr/mL, respectively, showing a significant decrease (p=0.010). The results indicate that the combined administration of both inhibitors is effective not only in decreasing blood glucose fluctuations and preventing postprandial insulin secretion. The beneficial effects may also protect the endocrine pancreas and inhibit body weight gain.
23
Heart Disease and Stroke Statistics—2007 Update
Wayne D. Rosamond, Katherine M. Flegal, Gary Friday et al. · Circulation · 2006 · 3.3K citations
Translating the A1C Assay Into Estimated Average Glucose Values
David M. Nathan, J.C. Kuenen, Rikke Borg et al. · Diabetes Care · 2008 · 1.8K citations · Full text